How much is enough? Modulation of dose-response curve for steroid receptor-regulated gene expression by changing concentrations of transcription factor

Current Topics in Medicinal Chemistry

Volumn 6, Issue 3, 2006, Pages 271-285

  Simons Jr , S Stoney ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Chaperone Proteins; Corepressors; Dissociation constant; Michaelis Menton kinetics; Receptor steroid interactions; Ubc9

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ACTIVIN; ADRENALIN; ANTIGESTAGEN; BETA ADRENERGIC RECEPTOR; CAMPTOTHECIN; CYPROTERONE ACETATE; DEXAMETHASONE; ESTROGEN RECEPTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HORMONE RECEPTOR AFFECTING AGENT; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; PROMEGESTONE; PROPRANOLOL; STEROID HORMONE; STEROID RECEPTOR; TAMOXIFEN; TRANSCRIPTION FACTOR;

CELL DIFFERENTIATION; CONCENTRATION RESPONSE; DOSE RESPONSE; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SENSITIVITY; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE REPRESSION; HOMEOSTASIS; HORMONE ACTION; HUMAN; MEDICAL RESEARCH; NONHUMAN; REVIEW; STEROID BLOOD LEVEL;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; RECEPTORS, STEROID; STEROIDS; TRANSCRIPTION FACTORS;

EID: 33646153793     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802606776173465     Document Type: Review

References (167)

1. Mercier, L.; Thompson, E.B.; Simons, Jr. S.S. Dissociation of steroid binding to receptors and steroid induction of biological activity in a glucocorticoid responsive cell. Endocrinology 1983, 112, 601-609.
2. Simons, Jr. S.S.; Yen, P.M. Variations in agonist activity among antiglucocorticoid steroids and its relation to glucocorticoid regulated genes. Steroid and Sterol Hormone Action 1987, 251-268.
3. Szapary, D.; Oshima, H.; Simons, Jr. S.S. Modulation of glucocorticoid induction of stably transfected tyrosine aminotransferase gene constructs involves elements up-stream of the glucocorticoid responsive element. Endocrinology 1992, 130, 3492-3502.
4. May, F.E.B.; Westley, B.R. Identification and characterization of estrogen-regulated RNAs in human breast cancer cells. J. Biol. Chem. 1988, 263, 12901-12908.
5. Barton, M.C.; Shapiro, D.J. Transient administration of estradiol-17? establishes an autoregulatory loop permanently inducing estrogen receptor mRNA. Proc. Natl. Acad. Sci. USA 1988, 85, 7119-7123.
6. Oshima, H.; Simons, Jr. S.S. Modulation of glucocorticoid induction of tyrosine aminotransferase gene expression by variations in cell density. Endocrinology 1992, 130, 2106-2112.
7. Oshima, H.; Simons, Jr. S.S. Modulation of transcription factor activity by a distant steroid modulatory element. Mol. Endocrinol. 1992, 6, 416-428.
8. Oshima, H.; Simons, Jr. S.S. Sequence-selective interactions of transcription factor elements with tandem glucocorticoid-responsive elements at physiological steroid concentrations. J. Biol. Chem. 1993, 268, 26858-26865.
9. Szapary, D.; Xu, M.; Simons, Jr. S.S. Induction properties of a transiently transfected glucocorticoid-responsive gene vary with glucocorticoid receptor concentration. J. Biol. Chem. 1996, 271, 30576-30582.
10. Lee, S.; Duncan, K.A.; Chou, H.; Chen, D.; Kohli, K.; Huang, C.-F.; Stallcup, M.R. A somatic cell genetic method for identification of untargeted mutations in the glucocorticoid receptor that cause hormone binding deficiencies. Mol. Endocrinol. 1995, 9, 826-837.
11. Vottero, A.; Kino, T.; Combe, H.; Lecomte, P.; Chrousos, G.P. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p 160 steroid receptor coactivators. J. Clin. Endocrinol. Metab. 2002, 87, 2658-2667.
12. Reese, J.C.; Wooge, C.H.; Katzenellenbogen, B.S. Identification of two cysteines closely positioned in the ligand- binding pocket of the human estrogen receptor: Roles in ligand binding and transcriptional activation. Mol. Endocrinol. 1992, 6, 2160-2166.
13. Chun, T.-Y.; Gregg, D.; Sarkar, D.K.; Gorski, J. Differential regulation by estrogens of growth and prolactin synthesis in pituitary cells suggests that only a small pool of estrogen receptors is required for growth. Proc. Natl. Acad. Sci. USA 1998. 95, 2325-2330.
14. Allgood, V.E.; Zhang, Y.; O'Malley, B.W.; Weigel, N.L. Analysis of chicken progesterone receptor function and phosphorylation using an adenovirus-mediated procedure for high-efficiency DNA transfer. Biochemistry 1997, 36, 224-232.
15. Mouchon, A.; Delmotte, M.-H.; Formstecher, P.; Lefebvre, P. Allosteric regulation of the discriminative responsiveness of retinoic acid receptor to natural and synthetic ligands by retinoid X receptor and DNA. Mol. Cell. Biol. 1999, 19, 3073-3085.
16. Blumberg, B.; Bolado, J. Jr.; Derguini, F.; Craig, A.G.; Moreno, T.A.; Chakravarti, D.; Heyman, R.A.; Buck, J.; Evans, R.M. Novel retinoic acid receptor ligands in Xenopus embryos. Proc. Natl. Acad. Sci. USA 1996, 93, 4873-4878.
17. Diamond, M.I.; Miner, J.N.; Yoshinaga, S.K.; Yamamoto, K.R. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 1990, 249, 1266-1272.
18. Wei, P.; Ahn, Y.I.; Housley, P.R.; Alam, J.; Vedeckis, W.V. Modulation of hormone-dependent glucocorticoid receptor function using a teracycline-regulated expression system. J. Steroid Biochem. Mol. Biol. 1998, 64, 1-12.
19. Kunz, S.; Sandoval, R.; Carlsson, P.; Carlstedt-Duke, J.; Bloom, J.W.; Miesfeld, R.L. Identification of a novel glucocorticoid receptor mutation in budesonide-resistant human bronchial epithelial cells. Mol. Endocrinol. 2003, 17, 2566-2582.
20. Nye, A.C.; Rajendran, R.R.; Stenoien, D.L.; Mancini, M.A.; Katzenellenbogen, B.S.; Belmont, A.S. Alteration of large-scale chromatin structure by estrogen receptor. Mol. Cell Biol. 2002, 22, 3437-3449.
21. Koubovec, D.; Ronacher, K.; Stubsrud, E.; Louw, A.; Hapgood, J.P. Synthetic progestins used in HRT have different glucocorticoid agonist properties. Mol. Cell. Endocrinol. 2005, in press.
22. Karim, F.D.; Thummel, C.S. Temporal coordination of regulatory gene expression by the steroid hormone ecdysone. EMBO J. 1992, 11, 4083-4093.
23. Orphanides, G.; Reinberg, D. A unified theory of gene expression. Cell 2002, 108, 439-451.
24. Xu, J.; Li, Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol. Endocrinol. 2003, 17, 1681-1692.
25. Gurdon, J.B.; Bourillot, P.Y. Morphogen gradient interpretation. Nature 2001, 413, 797-803.
26. Loeb, J.N.; Strickland, S. Hormone binding and coupled response relationships in systems dependent on the generation of secondary mediators. Mol. Endocrinol. 1987, 1, 75-82.
27. Yang, Y.-Z.; Subauste, J.S.; Koenig, R.J. Retinoid X receptor alpha binds with the highest affinity to an imperfect direct repeat response element. Endocrinology 1995, 136, 2896-2903.
28. Thenot, S.; Bonnet, S.; Boulahtouf, A.; Margeat, E.; Royer, C.A.; Borgna, J.-L.; Cavailles, V. Effect of ligand and DNA binding on the interaction between human transcription intermediary factor 1a and estrogen receptors. Mol. Endocrinol. 1999, 13, 2137-2150.
29. Reid, K.J.; Hendy, S.C.; Saito, J.L.; Sorensen, P.; Nelson, C.C. Two classes of androgen receptor elements mediate cooperativity through allosteric interactions. J. Biol. Chem. 2000, 276, 2943-2952.
30. Geserick, C.; Meyer, H.A.; Barbulescu, K.; Haendler, B. Differential modulation of androgen receptor action by deoxyribunucleic acid response elements. Mol. Endocrinol. 2003, 17, 1738-1750.
31. Simons, Jr., S.S. The importance of being varied in steroid receptor transactivation. TIPS 2003, 24, 253-259.
32. Chen, D.; Riedl, T.; Washbrook, E.; Pace, P.E.; Coombes, R.C.; Egly, J.M.; Ali, S. Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol. Cell 2000, 6, 127-137.
33. Jansen, M.S.; Nagel, S.C.; Miranda, P.J.; Lobenhofer, E.K.; Afshari, C.A.; McDonnell, D.P. Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition. Proc Natl Acad Sci USA 2004, 101, 7199-7204.
34. Szapary, D.; Huang, Y.; Simons, Jr. S.S. Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor regulated gene expression. Mol. Endocrinol. 1999, 13, 2108-2121.
35. Zuo, Z.; Urban, G.; Scammell, J.G.; Dean, N.M.; McLean, T.K.; Aragon, I.; Honkanen, R.E. Ser/Thr protein phosphatase type 5 (PP5)is a negative regulator of glucocorticoid receptor-mediated growth arrest. Biochemistry 1999, 38, 8849-8857.
36. Chen, S.; Sarlis, N.J.; Simons, Jr. S.S. Evidence for a common step in three different processes for modulating the kinetic properties of glucocorticoid receptor-induced gene transcription. J. Biol. Chem. 2000, 275, 30106-30117.
37. Zeng, H.; Plisov, S.Y.; Simons, Jr. S.S. Ability of the glucocorticoid modulatory element (GME) to modify glucocorticoid receptor transactivation indicates parallel pathways for the expression of GME and glucocorticoid response element activities. Mol. Cell. Endo. 2000, 162, 221-234.
38. He, Y.; Szapary, D.; Simons, Jr. S.S. Modulation of induction properties of glucocorticoid receptor-agonist and -antagonist complexes by coactivators involves binding to receptors but is independent of ability of coactivators to augment transactivation. J. Biol. Chem. 2002, 277, 49256-49266.
39. Kaul, S.; Blackford, Jr. J.A.; Cho, S.; Simons, Jr. S.S. Ubc9 is a novel modulator of the induction properties of glucocorticoid receptors. J. Mol. Chem. 2002, 277, 12541-12549.
40. Wang, Q.; Blackford, Jr. J.A.; Song, L.-N.; Huang, Y.; Simons, Jr. S.S. Equilibrium interactions of corepressors and coactivators modulate the properties of agonist and antagonist complexes of glucocorticoid receptors. Mol. Endocrinol. 2004, 18, 1376-1395.
41. Cho, S.; Kagan, B.L.; Blackford, Jr. J.A.; Szapary, D.; Simons, Jr. S.S. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of both the dose-response curve of receptor-agonist complexes and the partial agonist activity of receptor-antisteroid complexes by glucocorticoid receptors, coactivator TIF2, and Ubc9. Mol. Endo. 2005, 19, 290-311.
42. Massaad, C.; Houard, N.; Lombes, M.; Barouki, R. Modulation of human mineralocorticoid receptor function by protein kinase A. Mol. Endo. 1999, 13, 57-65.
43. Guiochon-Mantel, A.; Savouret, J.F.; Quignon, F.; Delabre, K.; Milgrom, E.; De The, H. Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors. Mol. Endocrinol. 1995, 9, 1791-1803.
44. Minucci, S.; Horn, V.; Bhattacharyya, N.; Russanova, V.; Ogryzko, V.V.; Gabrielle, L.; Howard, B.H.; Ozato, K. A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA 1997, 94, 11295-11300.
45. Green, M.R. Eukaryotic transcription activation: right on target. Mol. Cell. 2005, 18, 399-402.
46. Chen, T.L.; Hauschka, P.V.; Feldman, D. Dexamethasone increases 1,25-dihydroxyvitamin D3 receptor levels and augments bioresponses in rat osteoblast-like cells. Endocrinology 1986, 118, 1119-1126.
47. Webb, P.; Lopez, G.N.; Greene, G.L.; Baxter, J.D.; Kushner, P.J. The limits of the cellular capacity to mediate an estrogen response. Mol. Endocrinol. 1992, 6, 157-167.
48. Anzick, S.L.; Azorsa, D.O.; Simons, Jr. S.S.; Meltzer, P.S. Phenotypic alterations in breast cancer cells overexpressing the nuclear receptor co-activator AIB1. BMC Cancer 2003, 3, 22.
49. Wang, Q.; Richter, W.F.; Anzick, S.L.; Meltzer, P.S.; Simons, Jr., S.S. Modulation of transcriptional sensitivity of mineralocorticoid and estrogen receptors. J. Steroid Biochem. Molec. Biol. 2004, 91, 197-210.
50. Chen, C.D.; Welsbie, D.S.; Tran, C.; Baek, S.H.; Chen, R.; Vessella, R.; Rosenfeld, M.G.; Sawyers, C.L. Molecular determinants of resistance to antiandrogen therapy. Nat. Med. 2004, 10, 33-39.
51. Giannoukos, G.; Szapary, D.; Smith, C.L.; Meeker, J.E.W.; Simons, Jr. S.S. New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties. Mol. Endocrinol. 2001, 15, 255-270.
52. Song, L.-N.; Huse, B.; Rusconi, S.; Simons, Jr. S.S. Transactivation specificity of glucocorticoid vs. progesterone receptors: role of functionally different interactions of transcription factors with amino- and carboxyl-terminal receptor domains. J. Biol. Chem. 2001, 276, 24806-24816.
53. Cho, S.; Blackford, Jr. J.A.; Simons, Jr. S.S. Role of activation function domain 1, DNA binding, and coactivator in the expression of partial agonist activity of glucocorticoid receptor complexes. Biochemistry 2005, 44, 3547-3561.
54. McKenna, N.J.; O'Malley, B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002, 108, 465-474.
55. Nagy, L.; Schwabe, J.W. Mechanism of the nuclear receptor molecular switch. Trends Biochem. Sci. 2004, 29, 317-324.
56. Karvonen, U.; Janne, O.A.; Palvimo, J.J. Pure antiandrogens disrupt the recruitment of coactivator GRIP1 to colocalize with androgen receptor in nuclei. FEBS Lett 2002, 523, 43-47.
57. Cheng, S.; Brzostek, S.; Lee, S.R.; Hollenberg, A.N.; Balk, S.P. Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor. Mol. Endocrinol. 2002, 16, 1492-1501.
58. Berrevoets, C.A.; Umar, A.; Trapman, J.; Brinkmann, A.O. Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR). Biochem J 2004, 379, 731-738.
59. Shang, Y.; Brown, M. Molecular determinants for the tissue specificity of SERMs. Science 2002, 295, 2465-2468.
60. Wang, D.; Simons, Jr. S.S. Corepressor binding to progesterone and glucocorticoid receptors involves the AF-1 domain and is inhibited by molybdate. Mol. Endo. 2005, 19, 1483-1500.
61. Wagner, B.L.; Norris, J.D.; Knotts, T.A.; Weigel, N.L.; McDonnell, D.P. The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol. Cell. Biol. 1998, 18, 1369-1378.
62. Liu, Z.; Auboeuf, D.; Wong, J.; Chen, J.D.; Tsai, S.Y.; Tsai, M.J.; O'Malley, B.W. Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486. Proc. Natl. Acad. Sci. USA 2002, 99, 7940-7944.
63. Dennis, A.P.; Lonard, D.M.; Nawaz, Z.; O'Malley, B.W. Inhibition of the 26S proteasomè blocks progesterone receptor-dependent transcription through failed recruitment of RNA polymerase II. J. Steroid Biochem. Mol. Biol. 2005, 94, 337-346.
64. Sohn, Y.C.; Kim, S.W.; Lee, S.; Kong, Y.Y.; Na, D.S.; Lee, S.K.; Lee, J.W. Dynamic inhibition of nuclear receptor activation by corepressor binding. Mol. Endocrinol. 2003, 17, 366-372.
65. Gee, A.C.; Carlson, K.E.; Martini, P.G.V.; Katzenellenbogen, B.S.; JA, K. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor. Mol. Endocrinol. 1999, 13, 1912-1923.
66. Rowan, B.G.; Weigel, N.L.; O'Malley, B.W. Phosphorylation of steroid receptor coactivator-1. Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J. Biol. Chem. 2000, 275, 4475-4483.
67. Herdick, M.; Bury, Y.; Quack, M.; Uskokovic, M.R.; Polly, P.; Carlberg, C. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists. Mol. Pharmacol. 2000, 57, 1206-1217.
68. Hong, H.; Kohl, K.; Garabedian, M.J.; Stallcup, M.R. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol. Cell. Biol. 1997, 17, 2735-2744.
69. Fuqua, S.A.; Wiltschke, C.; Zhang, Q.X.; Borg, A.; Castles, C.G.; Friedrichs, W.E.; Hopp, T.; Hilsenbeck, S.; Mohsin, S.; O'Connell, P.; Allred, D.C. A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions. Cancer Res. 2000, 60, 4026-4029.
70. Chen, D.; Huang, S.M.; Stallcup, M.R. Synergistic, p160 coactivator-dependent enhancement of estrogen receptor function by CARM1 and p300. J. Biol. Chem. 2000, 275, 40810-40816.
71. Sheppard, H.M.; Harries, J.C.; Hussain, S.; Bevan, C.; Heery, D.M. Analysis of the steroid receptor coactivator 1 (SRC1)-CREB binding protein interaction interface and its importance for the function of SRC1. Mol. Cell. Biol. 2001, 21, 39-50.
72. Blanco, J.C.G.; Minucci, S.; Lu, J.; Yang, X.-J.; Walker, K.K.; Chen, H.; Evans, R.M.; Nakatani, Y.; Ozato, K. The histone acetylase PCAF is a nuclear receptor coactivator. Genes Develop. 1998, 12, 1638-1651.
73. Korzus, E.; Torchia, J.; Rose, D.W.; Xu, L.; Kurokawa, R.; McInerney, E.M.; Mullen, T.-M.; Glass, C.K.; Rosenfeld, M.G. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 1998, 279, 703-707.
74. Yang, X.-J.; Ogryzko, V.V.; Nishikawa, J.-; Howard, B.H.; Nakatani, Y. A p300/CBP associated factor that competes with the adenoviral oncoprotein E1A. Nature 1996, 382, 319-324.
75. Ko, L.; Cardona, G.R.; Henrion-Caude, A.; chin, W.W. Identification and characterization of a tissue-specific coactivator, GT198, that interacts with the DNA-binding domains of nuclear receptors. Mol. Cell Biol. 2002, 22, 357-369.
76. Smith, C.L.; Nawaz, Z.; O'Malley, B.W. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol. Endocrinol. 1997, 11, 657-666.
77. Joyeux, A.; Cavaillès, V.; Balaguer, P.; Nicolas, J.C. RIP 140 enhances nuclear receptor-dependent transcription in yeast. Mol. Endocrinol. 1997, 11, 193-202.
78. Huang, Z.Q.; Li, J.; Wong, J. AR possesses an intrinsic hormone-independent transcriptional activity. Mol. Endocrinol. 2002, 16, 924-937.
79. Wong, C.W.; Komm, B.; Cheskis, B.J. Structure-function evaluation of ER alpha and beta interplay with SRC family coactivators. ER selective ligands. Biochemistry 2001, 40, 6756-6765.
80. Schulz, M.; Eggert, M.; Baniahmad, A.; Dostert, A.; Heinzel, T.; Renkawitz, R. RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding. J. Biol. Chem. 2002, 277, 26238-26243.
81. Wang, Q.; Lu, J.; Yong, E.L. Ligand- and coactivator-mediated transactivation function (AF2) of the androgen receptor ligand-binding domain is inhibited by the cognate hinge region. J. Biol. Chem. 2001, 276, 7493-7499.
82. Dotzlaw, H.; Moehren, U.; Mink, S.; Cato, A.C.; Iniguez, L.J.A.; Baniahmad, A. The amino terminus of the human AR is target for corepressor action and antihormone agonism. Mol. Endocrinol. 2002, 16, 661-673.
83. Fu, M.; Wang, C.; Wang, J.; Zhang, X.; Sakamaki, T.; Yeung, Y.G.; Chang, C.; Hopp, T.; Fuqua, S.A.; Jaffray, E.; Hay, R.T.; Palvimo, J.J.; Janne, O.A.; Pestell, R.G. Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. Mol. Cell Biol. 2002, 22, 3373-3388.
84. Berry, M.; Metzger, D.; Chambon, P. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 1990, 9, 2811-2818.
85. Webb, P.; Nguyen, P.; Shinsako, J.; Anderson, C.; Feng, W.; Nguyen, M.P.; Chen, D.; Huang, S.M.; Subramanian, S.; McKinerney, E.; Katzenellenbogen, B.S.; Stallcup, M.R.; Kushner, P.J. Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Mol. Endocrinol. 1998, 12, 1605-1618.
86. Schaufele, F.; Chang, C.Y.; Liu, W.; Baxter, J.D.; Nordeen, S.K.; Wan, Y.; Day, R.N.; McDonnell, D.P. Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor. Mol. Endocrinol. 2000, 14, 2024-2039.
87. Steinmetz, A.C.; Renaud, J.P.; Moras, D. Binding of ligands and activation of transcription by nuclear receptors. Annu. Rev. Biophys. Biomol. Struct. 2001, 30, 329-359.
88. Shiau, A.K.; Barstad, D.; Radek, J.T.; Meyérs, M.J.; Nettles, K.W.; Katzenellenbogen, B.S.; Katzenellenbogen, J.A.; Agard, D.A.; Greene, G.L. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nat. Struct. Biol. 2002, 9, 359-364.
89. Tamrazi, A.; Carlson, K.E.; Rodriguez, A.L.; Katzenellenbogen, J.A. Coactivator proteins as determinants of estrogen receptor structure and function: spectroscopic evidence for a novel coactivator-stabilized receptor conformation. Mol Endocrinol 2005, 19, 1516-1528.
90. Rochette-Egly, C.; Plassat, J.L.; Taneja, R.; Chambon, P. The AF-1 and AF-2 activating domains of retinoic acid receptor-alpha (RARalpha) and their phosphorylation are differentially involved in parietal endodermal differentiation of F9 cells and retinoid-induced expression of target genes. Mol. Endocrinol. 2000, 14, 1398-1410.
91. Roy, S.; Garges, S.; Adhya, A. Activation and repression of transcription by differential contact: two sides of a coin. J. Biol. Chem. 1998, 273, 14059-14062.
92. Oshima, H.; Szapary, D.; Simons, Jr. S.S. The factor binding to the glucocorticoid modulatory element of the tyrosine aminotransferase gene is a novel and ubiquitous heteromeric complex. J. Biol. Chem. 1995, 270, 21893-21910.
93. Zeng, H.; Jackson, D.A.; Oshima, H.; Simons, Jr. S.S. Cloning and characterization of a novel binding factor (GMEB-2) of the glucocorticoid modulatory element. J. Biol. Chem. 1998, 273, 17756-17762.
94. Kaul, S.; Blackford, Jr. J.A.; Chen, J.; Ogryzko, V.V.; Simons, Jr., S.S. Properties of the glucocorticoid modulatory element binding proteins GMEB-1 and -2: potential new modifiers of glucocorticoid receptor transactivation and members of the family of KDWK proteins. Mol. Endocrinol. 2000, 14, 1010-1027.
95. Zeng, H.; Kaul, S.; Simons, Jr. S.S. Genomic organization of human GMEB-1 and rat GMEB-2: structural conservation of two multifunctional proteins. Nucleic Acids Res. 2000, 28, 1819-1829.
96. Chen, J.; Kaul, S.; Simons, Jr. S.S. Structure/activity elements of the multifunctional protein, GMEB-1. Characterization of domains relevant for the modulation of glucocorticoid receptor transactivation properties. J. Biol. Chem. 2002, 277, 22053-22062.
97. Chen, J.; He, Y.; Simons, Jr. S.S. Structure/activity relationships for GMEB-2: the second member of the glucocorticoid modulatory element binding complex. Biochemistry 2004, 43, 245-255.
98. Christensen, J.; Cotmore, S.F.; Tattersall, P. Two new members of the emerging KDWK family of combinatorial transcription modulators bind as a heterodimer to flexibly spaced PuCGPy halfsites [In Process Citation]. Mol. Cell. Biol. 1999, 19, 7741-7750.
99. Christensen, J.; Cotmore, S.F.; Tattersall, P. Minute virus of mice initiator protein NS1 and a host KDWK family transcription factor must form a precise ternary complex with origin DNA for nicking to occur. J. Virol. 2001, 75, 7009-7017.
100. Le, D.Y.; Mincheneau, N.; Le, G.P.; Michel, D. Potentiation of glucocorticoid receptor transcriptional activity by sumoylation. Endocrinology 2002, 143, 3482-3489.
101. Tian, S.; Poukka, H.; Palvimo, J.J.; Janne, O.A. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. Biochem. J. 2002, 367, 907-911
102. Sampson, D.A.; Wang, M.; Matunis, M.J. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 2001, 276, 21664-21669.
103. Gong, L.; Kamitani, T.; Fujise, K.; Caskey, L.S.; Yeh, E.T. Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9. J. Biol. Chem. 1997, 272, 28198-28201.
104. Chakrabarti, S.R.; Sood, R.; Ganguly, S.; Bohlander, S.; Shen, Z.; Nucifora, G. Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9. Proc. Natl. Acad. Sci. USA 1999, 96, 7467-7472.
105. Poukka, H.; Aarnisalo, P.; Karvonen, U.; Palvimo, J.J.; Janne, O.A. Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. J. Biol. Chem. 1999, 274, 19441-19446.
106. He, B.; Kemppainen, J.A.; Voegel, J.J.; Gronemeyer, H.; Wilson, E.M. Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH2-terminal domain. J. Biol. Chem. 1999, 274, 37219-37225.
107. Dubbink, H.J.; Hersmus, R.; Verma, C.S.; van der Korput, H.A.; Berrevoets, C.A.; van Tol, J.; Ziel-van der Made, A.C.; Brinkmann, A.O.; Pike, A.C.; Trapman, J. Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor. Mol. Endocrinol. 2004, 18, 2132-2150.
108. He, B.; Gampe, R.T.J.; Kole, A.J.; Hnat, A.T.; Stanley, T.B.; An, G.; Stewart, E.L.; Kalman, R.I.; Minges, J.T.; Wilson, E.M. Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance. Mol. Cell. 2004, 16, 425-438.
109. Pratt, W.B.; Toft, D.O. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp. Biol. Med. (Maywood) 2003, 228, 111-133.
110. Kaul, S.; Murphy, P.J.M.; Chen, J.; Brown, L.; Pratt, W.B.; Simons, Jr. S.S. Mutations at positions 547-553 of rat glucocorticoid receptors reveal that hsp90 binding requires the presence, but not defined composition, of a seven amino acid sequence at the amino terminus of the ligand binding domain. J. Biol. Chem. 2002, 277, 36223-36232.
111. Murphy, P.J.; Morishima, Y.; Kovacs, J.J.; Yao, T.P.; Pratt, W.B. Regulation of the dynamics of hsp90 action on the glucocorticoid receptor by acetylation/deacetylation of the chaperone. J. Biol. Chem. 2005, 280, 33792-33799.
112. Kovacs, J.J.; Murphy, P.J.; Gaillard, S.; Zhao, X.; Wu, J.T.; Nicchitta, C.V.; Yoshida, M.; Toft D.O.; Pratt, W.B.; Yao, T.P. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol. Cell. 2005, 18, 601-607.
113. Cheung-Flynn, J.; Prapapanich, V.; Cox, M.B.; Riggs, D.L.; Suarez-Quian, C.; Smith, D.F. Physiological role for the cochaperone FKBP52 in androgen receptor signaling. Mol. Endocrinol. 2005, 19, 1654-1666.
114. Montano, M.M.; Kraus, W.L.; Katzenellenbogen, B.S. Identification of a novel transferable cis element in the promoter of an estrogen-responsive gene that modulates sensitivity to hormone and antihormone. Mol. Endocrinol. 1997, 11, 330-341.
115. Chen, S.; Simons, Jr. S.S. A second pathway for the modulation of glucocorticoid receptor transactivation properties that involves hSur2. Mol. Cell. Endo. 2003, 199, 129-142.
116. Wang, G.; Balamotis, M.A.; Stevens, J.L.; Yamaguchi, Y.; Handa, H.; Berk, A.J. Mediator requirement for both recruitment and postrecruitment steps in transcription initiation. Mol. Cell. 2005, 17, 683-694.
117. Lu, M.L.; Schneider, M.C.; Zheng, Y.; Zhang, X.; Richie, J.P. Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J. Biol. Chem. 2001, 276, 13442-13451.
118. Norris, J.D.; Fan, D.; Sherk, A.; McDonnell, D.P. A negative coregulator for the human ER. Mol. Endocrinol. 2002, 16, 459-468.
119. McDonnell, D.P.; Vegeto, E.; O'Malley, B.W. Identification of a negative regulatory function for steroid receptors. Proc. Natl. Acad. Sci. USA 1992, 89, 10563-10567.
120. Wakui, J.; Wright, A.P.H.; Gustafsson, J.-; Zilliacus, J. Interaction of the ligand-activated glucocorticoid receptor with the 14-3-3? protein. J. Biol. Chem. 1997, 272, 8153-8156.
121. Le Douarin, B.; Zechel, C.; Garnier, J.-M.; Lutz, Y.; Tora, L.; Pierrat, B.; Heery, D.; Gronemeyer, H.; Chambon, P.; Losson, R. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 1995, 14, 2020-2033.
122. Kasbohm, E.A.; Guo, R.; Yowell, C.W.; Bagchi, G.; Kelly, P.; Arora, P.; Casey, P.J.; Daaka, Y. Androgen receptor activation by G(s) signaling in prostate cancer cells. J Biol. Chem. 2005, 280, 11583-11589.
123. Schmidt, P.; Holsboer, F.; Spengler, D. beta(2)-Adrenergic receptors potentiate glucocorticoid receptor transactivation via G protein betagamma-subunits and the phosphoinositide 3-kinase pathway. Mol. Endocrinol. 2001, 15, 553-564.
124. Qiu, M.; Olsen, A.; Faivre, E.; Horwitz, K.B.; Lange, C.A. Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors. Mol. Endocrinol. 2003, 17, 628-642.
125. Auboeuf, D.; Honig, A.; Berget, S.M.; O'Malley, B.W. Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 2002, 298, 416-419.
126. Auboeuf, D.; Dowhan, D.H.; Li, X.; Larkin, K.; Ko, L.; Berget, S.M.; O'Malley, B.W. CoAA, a nuclear receptor coactivator protein at the interface of transcriptional coactivation and RNA splicing. Mol. Cell. Biol. 2004, 24, 442-453.
127. Auboeuf, D.; Dowhan, D.H.; Kang, Y.K.; Larkin, K.; Lee, J.W.; Berget, S.M.; O'Malley, B.W. Differential recruitment of nuclear receptor coactivators may determine alternative RNA splice site choice in target genes. Proc. Natl. Acad. Sci. USA 2004, 101, 2270-2274.
128. Mittelstadt, P.R.; Ashwell, J.D. Disruption of glucocorticoid receptor exon 2 yields a ligand-responsive C-terminal fragment that regulates gene expression. Mol. Endo. 2003, 17, 1534-1542.
129. Stossi, F.; Barnett, D.H.; Frasor, J.; Komm, B.; Lyttle, C.R.; Katzenellenbogen, B.S. Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors. Endocrinology 2004, 145, 3473-3486.
130. Webb, M.S.; Miller, A.L.; Johnson, B.H.; Fofanov, Y.; Li, T.; Wood, T.G.; Thompson, E.B. Gene networks in glucocorticoid-evoked apoptosis of leukemic cells. J. Steroid Biochem. Mol. Biol. 2003, 85, 183-193.
131. Subramaniam, N.; Treuter, E.; Okret, S. Receptor interacting protein RIP140 inhibits both positive and negative gene regulation by glucocorticoids. J. Biol. Chem. 1999, 274, 18121-18127.
132. Rogatsky, I.; Zarember, K.A.; Yamamoto, K.R. Factor recruitment and TIF2/ GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones. EMBO J. 2001, 20, 6071-6083.
133. Rogatsky, I.; Luecke, H.F.; Leitman, D.C.; Yamamoto, K.R. Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts. Proc. Natl. Acad. Sci. USA 2002, 99, 16701-16706.
134. Zhao, Q.; Pang, J.; Favata, M.F.; Trzaskos, J.M. Receptor density dictates the behavior of a subset of steroid ligands in glucocorticoid receptor-mediated transrepression. Int. Immunopharmacol. 2003, 3, 1803-1817.
135. Liu, W.; Hillmann, A.; Harmon, J. Hormone-independent repression of AP-1-inducible collagenase promoter activity by glucocorticoid receptors. Mol. Cell. Biol. 1995, 15, 1005-1013.
136. Schier, A.F. Developmental biology: tail of decay. Nature 2004, 427, 403-404.
137. Reichardt, H.M.; Umland, T.; Bauer, A.; Kretz, O.; Schutz, G. Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock. Mol. Cell. Biol. 2000, 20, 9009-9017.
138. Visakorpi, T.; Hyytinen, E.; Koivisto, P.; Tanner, M.; Keinanen, R.; Palmberg, C.; Palotie, A.; Tammela, T.; Isola, J.; Kallioniemi, O.P. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat. Genet. 1995, 9, 401-406.
139. http://www.nursa.org/template.cfm?threadId=10222&dataType=Q- PCR&dataset=Tissue-specific%20expression%20patterns%20of% 20nuclear%20receptors.
140. Lu, N.Z.; Cidlowski, J.A. Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol. Cell 2005, 18, 331-342.
141. Geng, C.D.; Pedersen, K.B.; Nunez, B.S.; Vedeckis, W.V. Human glucocorticoid receptor alpha transcript splice variants with exon 2 deletions: evidence for tissue- and cell type-specific functions. Biochemistry 2005, 44, 7395-7405.
142. Webster, J.C.; Jewell, C.M.; Bodwell, J.E.; Munck, A.; Sar, M.; Cidlowski, J.A. Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. J. Biol. Chem. 1997, 272, 9287-9293.
143. Lange, C.A.; Shen, T.; Horwitz, K.B. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc. Natl. Acad. Sci. USA 2000, 97, 1032-1037.
144. Nawaz, Z.; Lonard, D.M.; Dennis, A.P.; Smth, C.L.; O'Malley, B.W. Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl. Acad. Sci. USA 1999, 96, 1858-1862.
145. Wallace, A.D.; Cidlowski, J.A. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J. Biol. Chem. 2001, 276, 42714-42721.
146. Nawaz, Z.; O'Malley, B.W. Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription? Mol. Endocrinol. 2004, 18, 493-499.
147. Mason, S.A.; Housley, P.R. Site-directed mutagenesis of the phosphorylation sites in the mouse glucocorticoid receptor. J. Biol. Chem. 1993, 268, 21501-21504.
148. Ismaili, N.; Blind, R.; Garabedian, M.J. Stabilization of the unliganded glucocorticoid receptor by TSG101. J. Biol. Chem. 2005, 280, 11120-11126.
149. Smith, J.S.; Kawa, S.; Cloyd, M.W.; Thompson, E.B. Interactions between human immunodeficiency virus infection and hormonal pathways: enhancement of calcium-induced but reduction of glucocorticoid-induced cell death. Endocrinology 1993, 133, 1085-1091.
150. Kawa, S.K.; Thompson, E.B. Lymphoid cell resistance to glucocorticoids in HIV infection. J. Steroid Biochem. Mol. Biol. 1996, 57, 259-263.
151. Visser, J.; Lentjes, E.; Haspels, I.; Graffelman, W.; Blauw, B.; de Kloet, R.; Nagelkerken, L. Increased sensitivity to glucocorticoids in peripheral blood mononuclear cells of chronic fatigue syndrome patients, without evidence for altered density or affinity of glucocorticoid
152. Anzick, S.L.; Kononen, J.; Walker, R.L.; Azorsa, D.O.; Tanner, M.M.; Guan, X.Y.; Sauter, G.; Kallioniemi, O.P.; Trent, J.M.; Meltzer, P.S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997, 277, 965-968.
153. Li, X.; Wong, J.; Tsai, S.Y.; Tsai, M.J.; O'Malley, B.W. Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Mol. Cell. Biol. 2003, 23, 3763-3773.
154. Pascual-Le Tallec, L.; Simone, F.; Viengchareun, S.; Meduri, G.; Thirman, M.J.; Lombes, M. The elongation factor ELL (eleven-nineteen lysine-rich leukemia) is a selective coregulator for steroid receptor functions. Mol. Endocrinol. 2005, 19, 1158-1169.
155. Planey, S.L.; Derfoul, A.; Steplewski, A.; Robertson, N.M.; Litwack, G. Inhibition of glucocorticoid-induced apoptosis in 697 pre-B lymphocytes by the mineralocorticoid receptor N-terminal domain. J. Biol. Chem. 2002, 277, 42188-42196.
156. Thackray, V.G.; Young, R.H.; Hooper, J.E.; Nordeen, S.K. Estrogen agonist and antagonist action on the human estrogen receptor in Drosophila. Endocrinology 2000, 141, 3912-3915.
157. Vegeto, E.; Allan, G.F.; Schrader, W.T.; Tsai, M.-J.; McDonnell, D.P.; O'Malley, B.W. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell 1992, 69, 703-713.
158. Garabedian, M.J.; Yamamoto, K.R. Genetic dissection of the signaling domain of a mammalian steroid receptor in yeast. Mol. Biol. Cell 1992, 3, 1245-1257.
159. Wright, A.P.H.; Gustafsson, J.-A. Glucocorticoid-specific gene activation by the intact human glucocorticoid receptor expressed in yeast. Glucocorticoid specificity depends on low level receptor expression. J. Biol. Chem. 1992, 267, 11191-11195.
160. Kralli, A.; Bohen, S.P.; Yamamoto, K.R. LEM1, an ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones. Proc. Natl. Acad. Sci. USA 1995, 92, 4701-4705.
161. Zajchowski, D.A.; Kauser, K.; Zhu, D.; Webster, L.; Aberle, S.; White, F.A.r.; Liu, H.L.; Humm, R.; MacRobbie, J.; Ponte, P.; Hegele-Hartung, C.; Knauthe, R.; Fritzemeier, K.H.; Vergona, R.; Rubanyi, G.M. Identification of selective estrogen receptor modulators by their gene expression fingerprints. J. Biol. Chem. 2000, 275, 15885-15894.
162. Luecke, H.F.; Yamamoto, K.R. The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. Genes Dev. 2005, 19, 1116-1127.
163. Geserick, C.; Meyer, H.A.; Haendler, B. The role of DNA response elements as allosteric modulators of steroid receptor function. Mol. Cell Endocrinol. 2005, 236, 1-7.
164. Koh, S.S.; Chen, D.; Lee, Y.H.; Stallcup, M.R. Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J. Biol. Chem. 2001, 276, 1089-1098.
165. Lee, Y.H.; Koh, S.S.; Zhang, X.; Cheng, X.; Stallcup, M.R. Synergy among nuclear receptor coactivators: selective requirement for protein methyltransferase and acetyltransferase activities. Mol. Cell Biol. 2002, 22, 3621-3632.
166. Li, H.; Kim, J.H.; Koh, S.S.; Stallcup, M.R. Synergistic effects of coactivators GRIP1 and beta-catenin on gene activation: cross-talk between androgen receptor and Wnt signaling pathways. J. Biol. Chem. 2004, 279, 4212-4220.
167. Keeton, E.K.; Brown, M. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT. Mol. Endocrinol. 2005, 19, 1543-1554.